Press Release

MediBang Paint Reaches 100M Downloads Worldwide / Contest With Prizes Valued At Almost One Million JPY Beginning Soon!

MediBang Paint, a program developed and operated by MediBang Inc., (HQ: Shibuya, Tokyo, CEO: Hideyuki Takashima), has now hit over ten million downloads.
MediBang has continued to strive for a service that creators can be satisfied with, with our goal of, “Everyone can be a Creator!”

MediBang Paint by the Numbers

We launched MediBang Paint in November of 2014.
We created this product with worldwide use in mind and offer compatibility in 18 different languages, becoming a service used by creators worldwide.
MediBang Paint is used by creators of all skill levels, from professional manga and comic artists to people just starting out with digital art. As a platform with the goal of expressing creativity, MediBang Paint transcends all barriers!

Win Amazing Prizes in the Illustration Contest!

 

In commemoration of 100M downloads, we here at MediBang are announcing an illustration contest!
There are many exciting prizes! In order to allow for even more participation this time around, submissions will be accepted from both ART street and X.

 

  • Contest Webpage (How to Participate): https://medibang.com/contest/mbp_100million/
  • Submission Period: October 4th ~ November 5th *All dates and times are JST.
  • Participating Platforms: ART street and X (formally Twitter)

Prizes

About US

Under our mission statement, “Everyone can be a Creator!”, we have developed and operate various creative software including MediBang Paint, with over 100M downloads, its premium version MediBang Pro, the JUMP Official Manga Creation Software, JUMP Paint, and many others. MediBang also owns and operates the illustration and manga community, ART street.

・MediBang HomePage: https://medibang.co.jp/
・・Official Instagram (English Only): https://www.instagram.com/medibangofficial
・Official X Page (Japanese Only): https://twitter.com/MediBangPaint


For Questions Regarding this Press Release
MediBang Inc. Press Liaison
e-mail: [email protected]